Blood pressure control improved with dual medication pills in India

Medication variations that combined two of three different blood pressure-lowering medications into a single pill worked equally well in reducing blood pressure and were safe among adults in India, according to late-breaking science presented today at the American Heart Association’s Scientific Sessions 2024.

Extending FDA-approved cancer drug indications requires high patient numbers, study finds

Number of patient participants needed for secondary approval of a new cancer drug.

September 29, 2023

Maryland biotech Georgiamune nabs $75M to fund three cancer, autoimmune clinical trials

Maryland biotech Georgiamune emerged Wednesday with a $75 million Series A, clearance to begin its first clinical trial later this year and a board that

August 10, 2023

What’s Next?— Predictions for What Happens After MDMA is Approved | Psychedelic Invest

The entire psychedelic industry is holding its breath in anticipation of the long-awaited FDA approval of MDMA. It will certainly be a big step for

June 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.